Welcome to the e-CCO Library!

P679: Development of a novel auto-injector of subcutaneous CT-P13 infliximab: Phase I randomised, open-label, single-dose trial to compare the pharmacokinetics and safety to pre-filled syringe in healthy subjects
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Schreiber*1, S. Ben-Horin2, B. D. Ye3, R. Westhovens4, D. H. Yoo5, S. J. Lee6, J. H. Suh6, J. H. Byeon6, W. Reinisch7

Created: Friday, 22 February 2019, 9:41 AM
P679: Inflammatory Bowel Disease and cancer risk in the IBSEN study after 30 years of follow-up.
Year: 2022
Source: ECCO'22
Authors: Follin-Arbelet, B.(1);Småstuen Cvancarova, M.(2);Hovde, Ø.(3);Jelsness-Jørgensen, L.P.(4);Moum, B.(2);
Created: Friday, 11 February 2022, 3:56 PM
P679: Infliximab biosimilar CT-P13 in inflammatory bowel disease patients that require intensification treatment
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Gompertz M., Alfaro I., Ricart E., Lόpez A., Panés J., Gallego M., Barastegui R., Giner A., Vara A., Masamunt M., Ordás I.

Created: Wednesday, 20 February 2019, 10:36 AM
P679: Is the burden of obesity in IBD bigger than just weight?
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Madigan, S.(1);Mountifield, R.(1)*;Barnes, A.(1);
Created: Friday, 14 July 2023, 11:12 AM
P679: Risk factors for disease relapse after stepping down from combination to anti-TNF monotherapy in children with IBD
Year: 2018
Source: ECCO '18 Vienna
Authors:

A. Yerushalmy-Feler*, S. Cohen

Created: Thursday, 21 February 2019, 9:14 AM
P679: The keystone bacterium Christensenella minuta improves colitis in in vivo preclinical Inflammatory Bowel Disease models
Year: 2021
Source: ECCO'21 Virtual
Authors: Kropp, C.(1);Le Corf, K.(2);Relizani, K.(2);Tambosco, K.(1);Martinez, C.(2);Chain, F.(1);Rawadi, G.(2);Langella, P.(1);Claus, S.(2);Martin, R.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P680: A real-life experience of Crohn's Disease Exclusion Diet use at disease onset and as an add-on therapy in pediatric Crohn's disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Scarallo, L.(1)*;Fioretti, L.(1);Pochesci, S.(1);Pierattini, V.(2);Banci, E.(2);De Blasi, A.(1);Di Paola, M.(1);Lionetti, P.(1,3);
Created: Friday, 14 July 2023, 11:12 AM
P680: Epidemiology of Inflammatory Bowel Disease in Poland 2009-2020: nationwide data
Year: 2022
Source: ECCO'22
Authors: Zagórowicz, E.S.(1);Walkiewicz, D.(2);Kucha, P.(1);Perwieniec, J.(2);Maluchnik, M.(2,3);Wieszczy, P.(4);Reguła, J.(4);
Created: Friday, 11 February 2022, 3:56 PM
P680: Long-term efficacy of ustekinumab with and without concomitant immunosuppressants for Crohn’s disease: results from IM-UNITI long-term extension through 2 years
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Ghosh*1, B. C. Kramer2, C. Gasink2, D. Jacobstein3, O. J. Adedokun3, L-L. Gao3, P. Rutgeerts4, B. E. Sands5

Created: Friday, 22 February 2019, 9:41 AM
P680: Machine learning (ML) in RCU-operated patients: Can we predict postoperative complications?
Year: 2018
Source: ECCO '18 Vienna
Authors:

L. Sofo*, P. Caprino, A.E. Potenza, F. Sacchetti, C.A. Schena

Created: Thursday, 21 February 2019, 9:14 AM
P680: Quality of sex life in patients with inflammatory bowel disease: the gastroenterologists' perspective
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Rivière P., Laharie D., Zerbib F., Poullenot F.

Created: Wednesday, 20 February 2019, 10:36 AM
P680: Similar gut bacterial composition between patients with ulcerative colitis and healthy controls in a high prevalence population: a cross-sectional study of the Faroe Islands IBD cohort
Year: 2021
Source: ECCO'21 Virtual
Authors: Á Fríðriksmørk BerbisáCand.Scient, M.(1);Rubek Nielsen, K.(2);Midjord, J.(2);Oddmarsdóttir Gregersen , N.(3);Ingham, A.C.(4);Burisch, J.(5);Gratton Vang, A.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P681 Efficacy of vedolizumab for the prevention of postoperative recurrence in Crohn’s disease: Data from clinical practice from the ENEIDA registry
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Mañosa Ciria1, E. Hinojosa2, A. Carbajo3, J. Castro4, N. Manceñido5, M. Calvo6, A. Núñez Alonso7, J. P Gisbert8, P. Nos9, J. Guardiola10, E. Sainz11, E. Sánchez-Rodríguez12, F. Cañete1, M. Calafat1, E. Domènech1, Eneida Registry

Created: Thursday, 30 January 2020, 10:12 AM
P681: Assessing internet based information used to aid patient decision making in surgery for perianal Crohn's fistula
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Marshall J.*1, Baker D.1, Lee M.2, Jones G.3, Lobo A.4, Brown S.2

Created: Wednesday, 20 February 2019, 10:36 AM
P681: Effectiveness and safety of oral Tacrolimus salvage therapy for acute severe ulcerative colitis: a retrospective study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Tamir-Degabli, N.(1)*;Cohen, N.A.(2);Hirsch, A.(3);Fishman, S.(2);Ron, Y.(2);Thrum, T.(2);Maharshak, N.(2);
Created: Friday, 14 July 2023, 11:12 AM
P681: Higher in vitro mucin degradation, but no increased paracellular permeability by faecal water from Crohn’s disease patients
Year: 2021
Source: ECCO'21 Virtual
Authors: Becker, H.(1);Kameli, N.(2);Rustichelli, A.(1);Britt, H.(1);Stassen, F.(2);Penders, J.(2);Jonkers, D.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P681: Impact of Crohn’s disease on survival in Korean patients with small bowel adenocarcinoma
Year: 2022
Source: ECCO'22
Authors: Kim, K.(1);Choi, K.(2);Hwang, S.W.(1);Im, J.P.(2);Ye, B.D.(1);Kim, J.S.(2);Yang, S.K.(1);Koh, S.J.(2);Park, S.H.(1);
Created: Friday, 11 February 2022, 3:56 PM
P681: Systematic review and meta-analysis of the safety and efficacy of intra-fistular injections of mesenchymal stem cells in clinical trials and observational cohort studies
Year: 2018
Source: ECCO '18 Vienna
Authors:

R. Ciccocioppo1*, C. Klersy2, D. Leffler3, R. Rogers3, D. Bennett3, G.R. Corazza4

Created: Thursday, 21 February 2019, 9:14 AM
P681: Ustekinumab therapy induced clinically meaningful improvement and remission as measured by the Inflammatory Bowel Disease Questionnaire: Results from the phase 3 UNIFI induction and maintenance studies
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

B. E. Sands*1, C. Han2, H. Zhang3, J. Johanns3, P. Szapary3, C. Marano3, R. W. Leong4,5, S. Danese6

Created: Friday, 22 February 2019, 9:41 AM